Lyra Therapeutics, Inc. (LYRA)
0.01
-0.19
(-95.00%)
USD |
OTCM |
Aug 31, 16:00
Lyra Therapeutics Debt to Equity Ratio : -2.824 for Dec. 31, 2025
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2025 | -2.824 |
| September 30, 2025 | -7.250 |
| June 30, 2025 | 20.02 |
| March 31, 2025 | 8.615 |
| December 31, 2024 | 2.965 |
| September 30, 2024 | 1.713 |
| June 30, 2024 | 1.186 |
| March 31, 2024 | 0.4885 |
| December 31, 2023 | 0.3006 |
| September 30, 2023 | 0.0747 |
| June 30, 2023 | 0.0171 |
| March 31, 2023 | 0.0316 |
| December 31, 2022 | 0.0517 |
| Date | Value |
|---|---|
| September 30, 2022 | 0.007 |
| June 30, 2022 | 0.0087 |
| March 31, 2022 | 0.0514 |
| December 31, 2021 | 0.0423 |
| September 30, 2021 | 0.0362 |
| June 30, 2021 | 0.0341 |
| March 31, 2021 | 0.0326 |
| December 31, 2020 | 0.0327 |
| September 30, 2020 | 0.033 |
| June 30, 2020 | 0.0334 |
| March 31, 2020 | 0.0931 |
| December 31, 2019 | 0.4539 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 36.11M |
| Total Liabilities (Quarterly) | 46.82M |
| Shareholders Equity (Quarterly) | -10.72M |
| Current Ratio | 1.709 |
| Net Debt Paydown Yield | 18.53% |